81950-33-6 Usage
Uses
Since the specific properties and potential applications of [4-(imidazo[2,1-b][1,3]benzothiazol-2-yl)phenyl]acetic acid have not been extensively studied or documented, it is difficult to provide a detailed list of uses. However, based on its chemical structure and classification, it can be inferred that [4-(imidazo[2,1-b][1,3]benzothiazol-2-yl)phenyl]acetic acid may have potential applications in the pharmaceutical industry, possibly as a starting material for the development of new drugs or as a compound with potential therapeutic properties.
Used in Pharmaceutical Industry:
[4-(imidazo[2,1-b][1,3]benzothiazol-2-yl)phenyl]acetic acid is used as a chemical compound for potential pharmaceutical applications due to its complex structure and the presence of biologically active heterocycles. Further research and development are required to explore its full potential and establish its specific uses in the industry.
Check Digit Verification of cas no
The CAS Registry Mumber 81950-33-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,1,9,5 and 0 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 81950-33:
(7*8)+(6*1)+(5*9)+(4*5)+(3*0)+(2*3)+(1*3)=136
136 % 10 = 6
So 81950-33-6 is a valid CAS Registry Number.
81950-33-6Relevant academic research and scientific papers
Synthesis and Anthiinflammatory Activity of Some Arylimidazothiazolyl- and Arylimidazobenzothiazolyl-acetic Acids
Sawhney, S. N.,Kodali, Dharma R.,Dhindsa, G. S.,Singh, S. P.
, p. 134 - 138 (2007/10/02)
Three series of the title compounds, imidazothiazolyl-, imidazobenzothiazolyl- and imidazobenzothiazolylaryl-acetic acids (II,III and IV) have been synthesised for evaluation as potential anti-inflammatory agents.Compounds II have been synthesised by condensing ethyl (2-amino-4-aryl-5-thiazolyl)acetate (VI) with phenacyl bromides followed by hydrolysis of the resultant esters (VII).III are obtained by the condensatiion of ethyl 2-aminobenzothiazole-6-acetate with phenacyl bromides followed by hydrolysis of the resultant esters (IX).Compound IV result from the treatment of 2-aminobenzothiazoles with ethyl 4(ω-bromoacetylphenyl)acetate (XI) followed by hydrolysis of the esters (XII).Some of the title compounds show good antiinflammatory activity.
